Correlation Between Virpax Pharmaceuticals and AptarGroup
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and AptarGroup at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and AptarGroup into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and AptarGroup, you can compare the effects of market volatilities on Virpax Pharmaceuticals and AptarGroup and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of AptarGroup. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and AptarGroup.
Diversification Opportunities for Virpax Pharmaceuticals and AptarGroup
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Virpax and AptarGroup is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and AptarGroup in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AptarGroup and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with AptarGroup. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AptarGroup has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and AptarGroup go up and down completely randomly.
Pair Corralation between Virpax Pharmaceuticals and AptarGroup
If you would invest 25.00 in Virpax Pharmaceuticals on May 28, 2025 and sell it today you would earn a total of 0.00 from holding Virpax Pharmaceuticals or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 1.59% |
| Values | Daily Returns |
Virpax Pharmaceuticals vs. AptarGroup
Performance |
| Timeline |
| Virpax Pharmaceuticals |
Risk-Adjusted Performance
Weakest
Weak | Strong |
| AptarGroup |
Virpax Pharmaceuticals and AptarGroup Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virpax Pharmaceuticals and AptarGroup
The main advantage of trading using opposite Virpax Pharmaceuticals and AptarGroup positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, AptarGroup can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptarGroup will offset losses from the drop in AptarGroup's long position.| Virpax Pharmaceuticals vs. MetaVia | Virpax Pharmaceuticals vs. Indaptus Therapeutics | Virpax Pharmaceuticals vs. Pasithea Therapeutics Corp | Virpax Pharmaceuticals vs. Quoin Pharmaceuticals Ltd |
| AptarGroup vs. ICU Medical | AptarGroup vs. AngioDynamics | AptarGroup vs. Haemonetics | AptarGroup vs. The Cooper Companies, |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |